Market Movers: Abiomed (ABMD) Gains 5.21% to Close at $248.62 June 23

Equities Staff  |

Shares of Abiomed Inc. (NASDAQ:ABMD) traded 5.21% up on June 23 to close at $248.62.

306,141 traded hands. Their current average 30 day volume is 298,545 shares.

Abiomed is down 34.21% year-to-date in 2022.

The company is set to release earnings on 2022-08-03.

For technical charts, analysis, and more on Abiomed visit the company profile.

About Abiomed Inc.

Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.

To get more information on Abiomed Inc. and to follow the company's latest updates, you can visit the company's profile page here: Abiomed Inc.'s Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets

Market Movers

Sponsored Financial Content